Cite
APA Citation
Tu, Y., Xiong, Z., Zhong, C., Wu, H., Wang, J., Wong, P. P., Yang, W., Zhou, J., To, K., Sung, J., Chan, S. L., Kerr, D., Thangue, N. L., & Cheng, A. S. (n.d.). iDDF2022-ABS-0103 A selective class I HDAC inhibitor recovers intratumoral interferon signaling to overcome immune-checkpoint blockade resistance in hepatocellular carcinoma. Gut, 71, A18. http://access.bl.uk/ark:/81055/vdc_100163576071.0x000064